1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
5[1]Kreczko S,Lipska A,Wysocka J.Alfa-fetoprotein:diagnostic value in hepatic disorders[J].Pol Merkuriusz Lek,2000,8 (48):420-423.
6[2]Mita Y,Aoyagi Y,Suda T,et al.Plasma fucosyltransferase activity in patients with hepatocellular carcinoma with special reference to correlation with fucosylated species of alpha-fetoprotein[J].J Hepatol,2000,32:946 -954.
7[3]Peto J.Cancer epidemiology in the last century and the next decade[J].Nature,2001,411:390-395.
8[4]Shigetoshi F,Motohiko T,Seishi M,et al.Tumor markers in early diagnosis,follow-up and management of patients with hepatocellular carcinoma[J].Oncology,2002,62(S1):57-63.
9[5]Chu P G,Ishizawa S,Wu E,et al.Hepatocyte antigen as a marker of hepatocellular carcinoma:an immunohistochemical comparison to carcinoembryonic antigen,CD10,and alpha-fetoprotein[J].Am J Surg Pathol,2002,26 (8):978-88.
10[6]Yamamoto R,Azuma M,Hoshi N,et al.Lens culinaris agglutinin-reactive alpha-fetoprotein,an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome[J].Hum Reprod,2001,16(11):2438-4424.
